Blog

Artificial intelligence.
Human ingenuity.

AlignBio Tournament 2024: Exazyme Achieves Top-Tier Rankings, Highlighting the Power of Its Cutting-Edge Algorithms

Exazyme excels at AlignBio Tournament 2023 and showcases the power of its cutting-edge algorithms. More than 30 teams participated in the first benchmarking event and were asked to show their computationl Protein Prediction and Design capabilities.

Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network

Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network

Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Exazyme shares their vision on optimizing proteins, from enzymes to anti-bodies. Embark on our latest projects and next steps.

Biochemical stars meet Artificial Intelligence: The startup Exazyme uses machine learning to develop blueprints for new enzymes.

Exazyme, initially started as an EXIST Gründerstipendium and Spin-Off from Freie Universität Berlin, has now successfully raised their first VC-investment.

Faces of Future: Dr. Ingmar Schuster

Ingmar Schuster, Exazyme CEO, pioneers AI-driven protein development at Startup Villa, revolutionizing industries for sustainability and efficiency.

Season 1

Painful Intelligence: Aapo Hyvärinen on the Concept of Suffering, Drawing Parallels between Humans and AI, and Conclusions for AI Ethics.

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Faces of Future: Dr. Ingmar Schuster

Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Follow us on LinkedIn for the latest updates